A citation-based method for searching scientific literature

G Geller, J R Botkin, M J Green, N Press, B B Biesecker, B Wilfond, G Grana, M B Daly, K Schneider, M J Kahn. JAMA 1997
Times Cited: 156







List of co-cited articles
697 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
S Thorlacius, J P Struewing, P Hartge, G H Olafsdottir, H Sigvaldason, L Tryggvadottir, S Wacholder, H Tulinius, J E Eyfjörd. Lancet 1998
266
6


The use of videotaped information in cancer genetic counselling: a randomized evaluation study.
A Cull, H Miller, T Porterfield, J Mackay, E D Anderson, C M Steel, R A Elton. Br J Cancer 1998
97
6


Generic consent for genetic screening.
S Elias, G J Annas. N Engl J Med 1994
112
6


Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
C Lerman, C Hughes, R T Croyle, D Main, C Durham, C Snyder, A Bonney, J F Lynch, S A Narod, H T Lynch. Prev Med 2000
184
6

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
C R Boland, S N Thibodeau, S R Hamilton, D Sidransky, J R Eshleman, R W Burt, S J Meltzer, M A Rodriguez-Bigas, R Fodde, G N Ranzani,[...]. Cancer Res 1998
6

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
631
6

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.
L A Aaltonen, R Salovaara, P Kristo, F Canzian, A Hemminki, P Peltomäki, R B Chadwick, H Kääriäinen, M Eskelinen, H Järvinen,[...]. N Engl J Med 1998
882
6


Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
999
6

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
865
6

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
628
6

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.
D F Easton, L Steele, P Fields, W Ormiston, D Averill, P A Daly, R McManus, S L Neuhausen, D Ford, R Wooster,[...]. Am J Hum Genet 1997
266
5

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.
M A Unger, K L Nathanson, K Calzone, D Antin-Ozerkis, H A Shih, A M Martin, G M Lenoir, S Mazoyer, B L Weber. Am J Hum Genet 2000
118
5


Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
431
5


Risk communication in genetic testing for cancer susceptibility.
R T Croyle, C Lerman. J Natl Cancer Inst Monogr 1999
111
5

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
128
5

Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
427
5


Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
M Dorval, A F Patenaude, K A Schneider, S A Kieffer, L DiGianni, K J Kalkbrenner, J I Bromberg, L A Basili, K Calzone, J Stopfer,[...]. J Clin Oncol 2000
100
5

Very high risk of cancer in familial Peutz-Jeghers syndrome.
F M Giardiello, J D Brensinger, A C Tersmette, S N Goodman, G M Petersen, S V Booker, M Cruz-Correa, J A Offerhaus. Gastroenterology 2000
791
5

Genetic discrimination: perspectives of consumers.
E V Lapham, C Kozma, J O Weiss. Science 1996
196
5

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
T R Rebbeck, A M Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, C Isaacs, O Olopade, J E Garber, A K Godwin,[...]. J Natl Cancer Inst 1999
457
5

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
T Powles, R Eeles, S Ashley, D Easton, J Chang, M Dowsett, A Tidy, J Viggers, J Davey. Lancet 1998
639
5


Discrimination as a consequence of genetic testing.
P R Billings, M A Kohn, M de Cuevas, J Beckwith, J S Alper, M R Natowicz. Am J Hum Genet 1992
318
5

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
105
5

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.
S J Laken, G M Petersen, S B Gruber, C Oddoux, H Ostrer, F M Giardiello, S R Hamilton, H Hampel, A Markowitz, D Klimstra,[...]. Nat Genet 1997
473
5




Psychologic aspects of cancer genetic testing: a research update for clinicians.
Robert T Croyle, Jennifer S Achilles, Caryn Lerman. Cancer 1997
38
13


Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Emily A Peterson, Kara J Milliron, Karen E Lewis, Susan D Goold, Sofia D Merajver. Cancer Epidemiol Biomarkers Prev 2002
92
5

Goals of genetic counseling.
B B Biesecker. Clin Genet 2001
119
5

Stress and genetic testing for disease risk.
A Baum, A L Friedman, S G Zakowski. Health Psychol 1997
96
5

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Donald A Berry, Edwin S Iversen, Daniel F Gudbjartsson, Elaine H Hiller, Judy E Garber, Beth N Peshkin, Caryn Lerman, Patrice Watson, Henry T Lynch, Susan G Hilsenbeck,[...]. J Clin Oncol 2002
326
5

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Asad Umar, C Richard Boland, Jonathan P Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Rüschoff, Richard Fishel, Noralane M Lindor, Lawrence J Burgart, Richard Hamelin,[...]. J Natl Cancer Inst 2004
5

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
Angela Trepanier, Mary Ahrens, Wendy McKinnon, June Peters, Jill Stopfer, Sherry Campbell Grumet, Susan Manley, Julie O Culver, Ronald Acton, Joy Larsen-Haidle,[...]. J Genet Couns 2004
144
5

Mutation and cancer: statistical study of retinoblastoma.
A G Knudson. Proc Natl Acad Sci U S A 1971
4

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients.
A Petrij-Bosch, T Peelen, M van Vliet, R van Eijk, R Olmer, M Drüsedau, F B Hogervorst, S Hageman, P J Arts, M J Ligtenberg,[...]. Nat Genet 1997
348
4

Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations.
L J Pierce, M Strawderman, S A Narod, I Oliviotto, A Eisen, L Dawson, D Gaffney, L J Solin, A Nixon, J Garber,[...]. J Clin Oncol 2000
179
4

Society of Surgical Oncology: statement on genetic testing for cancer susceptibilty. Committee on Issues and Governmental Affairs of the Society of Surgical Oncology.
V S Klimberg, S Galandiuk, E S Singletary, A Cohen, S Sener, M S Talamonti, T R Witt, J E Niederhuber, M J Edwards. Ann Surg Oncol 1999
9
44

Conversion of diploidy to haploidy.
H Yan, N Papadopoulos, G Marra, C Perrera, J Jiricny, C R Boland, H T Lynch, R B Chadwick, A de la Chapelle, K Berg,[...]. Nature 2000
204
4



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.